期刊文献+

C-myc,c-erbB-2癌基因在宫颈癌中的表达及其临床意义 被引量:2

Study on c-myc,c-erbB-2 Expression in Cervical Carcinoma and Their Clinical Significance
下载PDF
导出
摘要 目的 探讨c -myc ,c -erbB - 2两种癌基因在宫颈癌中表达及其临床意义。 方法 应用免疫组化法检测宫颈癌组织与CIN、正常宫颈组织标本中c -myc ,c-erbB - 2蛋白的表达 ,分析这两种蛋白表达与临床病理及预后的关系。结果 宫颈癌组织c -myc蛋白表达率 :宫颈癌组织为 40 .0 0 %,正常宫颈组织为 10 .0 0 %,CIN为2 0 .0 0 %,表达与病理分类有关 ,腺癌表达率高于鳞癌 ,但差异无显著性 (P >0 .0 5 ) ;过表达与临床分期及病理学分级相关 (P <0 .0 5 )。宫颈癌组织c -erbB - 2表达率为 37.5 0 %,正常宫颈组织未见阳性表达 ,仅 1例重度CIN弱表达 ,腺癌表达率 (6 6 .6 7%)高于鳞癌 (32 .35 %) ,但无显著性差异 (P >0 .0 5 ) ,鳞癌过表达与复发有关。C -myc ,c -erbB - 2两种基因在宫颈癌中表达差异无显著性 (P >0 .0 5 )。结论 C -myc表达与宫颈癌发生发展有一定关系 ;c-erbB - 2表达是细胞恶性变的标志 ,宫颈鳞癌中过表达与复发有关。 Objective To investigate the expressions of c-myc and c-erbB-2 in cervical carcinoma and their significance.Method Expression of c-myc. and c-erbB-2 proteins was examined immunohistochemically in 40 cases of carcinoma of the uterine cervix and 10 cases of CIN and 10 cases of cervical epithelium. The relationship between their expression with clinicpathologic factors and prognosis was analyzed by chi-square test.Results The expression rate of c-myc was 40.00% in cervical carcinoma and 20.00% in CIN and 10.00% in cervical epithelium(P<0.05). The expression was in connection with histological grade and clinic types.(P<0.05).The expression rate of c-erbB-2 was37.50% in cervical carcinoma and was none in cervical epithelium.and was10.00% in CIN. The expression of squamous cell carcinoma was in connection with relapse.There was no relationship between expression of C-myc and c-erbB-2(P>0.05).Conclusion Expression of c-myc is relevant to progression of cervical carcinoma; Expression of c-erbB-2 is a signal of cells become malignant and is relevant to relapse in squamous cell carcinoma.
出处 《苏州大学学报(医学版)》 CAS 2002年第2期179-179,共1页 Suzhou University Journal of Medical Science
关键词 宫颈癌 癌基因 C-MYC C-ERBB-2 免疫组化 蛋白表达 cervix carcinoma oncogens c-myc c-erbB-2 immunohistopathdoyy
  • 相关文献

参考文献6

  • 1Iwasaka T,Yokoyama m,Oh uchida M,et al.Detection of human papillomavirus genome and analysis of expression of c-myc and Ha-ras oncogenes in invasive cervial carcinomas[].Gynecologic Oncology.1992
  • 2Difior PP,Pieree JH,Kraus MH,et al.erbB-2 is a potent oncogene when overxpressed is NIH-ST3[].Science.1987
  • 3Hale RJ,Buckley CH,Fox H,et al.Prognositic valve of c-erbB-2 expressio in uterine cervical carcinoma[].Journal of Clinical Pathology.1992
  • 4Hudziak RM,Schlessinger J,Ullrich A,et al.Increased expression of the putation growth factor receptor P185/HER2 Causes transformation and tumorigenesis of NIHST3 cell[].Proceedings of the National Academy of Sciences of the United States of America.1987
  • 5Polacarz- SV,Darne- J,Sheridian- EG,et al.Endocervical carcinoma and precursor lesion: c- myc expression and the demonstration of field changs[].Journal of Clinical Pathology.1991
  • 6Sato S,Ito K,Ozawa N,et al.Expression of c-myc,epidermal growth factor receptor and c-erbB2 in human endometrial carcinoma and cervical adenocarcinoma[].Tohoku Journal of Experimental Medicine.1991

同被引文献11

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部